Anna Kula

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression

Gilles Darcis, Anna Kula, Sophie Bouchat et al. · PLoS Pathogens · 2015 · 286 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Fast transcription rates of RNA polymerase II in human cells

Paolo Maiuri, Anna Knezevich, Alex de Marco et al. · EMBO Reports · 2011 · 90 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1

Sophie Bouchat, Nadège Delacourt, Anna Kula et al. · EMBO Molecular Medicine · 2015 · 87 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function

Anna Kula, Jessica Guerra, Anna Knezevich et al. · Retrovirology · 2011 · 86 citations · Full text

Life Sciences, Biology, Molecular Biology +13

Transcriptional competence of the integrated HIV‐1 provirus at the nuclear periphery

Mariacarolina Dieudonné, Paolo Maiuri, Chiara Biancotto et al. · The EMBO Journal · 2009 · 74 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +16